Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Curasan AG       

CURASAN AG

SummaryNewsCalendarCompany 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

curasan : New CEO at curasan AG

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/12/2019 | 05:35am EDT

DGAP-Ad-hoc: curasan AG / Key word(s): Personnel
New CEO at curasan AG

12-Sep-2019 / 11:30 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


New CEO at curasan AG

Kleinostheim, September 12, 2019 - The supervisory board of curasan AG (DE000A2YPGM4) today has resolved to appoint Mr. Torben Sorensen as the new CEO of the company as of September 16, 2019 until the end of 31 December 2020.

Torben Sorensen will succeed Michael Schlenk, whose contract anyway expires on September 30, 2019, and whose request for early resignation effective as of the end of September 15, 2019 has been accepted today by the Supervisory Board as well.

Torben Sorensen is a Danish citizen currently living and working in Switzerland. He has been a successful, internationally active interim manager for more than 15 years and has reputation as a turnaround specialist in high-tech companies. Torben Sorensen is also active as a venture capital manager and was CEO of a successful dental med-tech company in Sweden.

---- End of the ad hoc release ----


Contact curasan AG:
Andrea Weidner
Investor Relations &
Corporate Communications
+49 6027 40 900-51
ir@curasan.com


12-Sep-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: curasan AG
Lindigstraße 4
63801 Kleinostheim
Germany
Phone: 06027/40 900 0
Fax: 06027/40 900 29
E-mail: info@curasan.de
Internet: www.curasan.de
ISIN: DE000A2YPGM4
WKN: A2YPGM
Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 872675

 
End of Announcement DGAP News Service

872675  12-Sep-2019 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=872675&application_name=news&site_id=zonebourse

© EQS 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CURASAN AG
10/01CURASAN : launches product for the treatment of the spinal facet syndrome
EQ
09/12CURASAN : New CEO at curasan AG
PU
09/12CURASAN : Torben Sorensen new CEO at curasan AG
PU
09/12CURASAN : Torben Sorensen new CEO at curasan AG
EQ
09/12CURASAN : New CEO at curasan AG
EQ
09/10CURASAN AG : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
08/22CURASAN : still on track despite of weaker second quarter
PU
08/22CURASAN : still on track despite of weaker second quarter
EQ
07/03CURASAN : takes over dental company with innovative technology
PU
More news
Managers
NameTitle
Torben Sorensen Chief Executive Officer
Detlef Wilke Chairman-Supervisory Board
Fabian Peters Technical Director
Christine Böhm Chief Medical Officer
Isabella de Krassny Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
CURASAN AG10
CSL LIMITED35.54%77 980
BIOGEN INC.-26.87%40 589
ALEXION PHARMACEUTICALS1.08%22 066
SAMSUNG BIOLOGICS CO LTD--.--%19 301
GRIFOLS19.13%18 295